Receive Email Updates
Certified Licensing Professionals, Inc., 2021
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner
Tag Archives: DNA
Dolly Led to Slaughter – Part II
As I read and re-read In re Roslin, App. No. 2013-1407 (Fed. Cir., May 8, 2014), before going across the street to “testify” at the PTO 101 Forum, I was struck by how the logical pathway chosen by the panel … Continue reading
Posted in Patent Eligible Subject Matter Tagged cloning, DNA, dolly, Federal Circuit, Roslin, Supreme Court, USPTO, Warren Woessner Leave a comment
Sanofi-Aventis v. Pfizer – Possession and Appreciation Trump Structure
On Tuesday, the Fed. Cir. affirmed a finding by the Board that Pfizer was entitled to an earlier priority date for a claim to cDNA encoding the IL-13 receptor protein (Sanofi-Aventis v. Pfizer, Inc., App. No. 2012-1345 (Fed. Cir. November … Continue reading
Complimentary Webinar: Patenting DNA
Join Robin Chadwick and me as we untangle the web of rulings in the upcoming webinar “Patenting DNA: Why DNA is Different and What to Do About It.” The live CLE webinar will be presented on Wednesday, August 7th at … Continue reading
Posted in Patent Eligible Subject Matter, Webinar Tagged DNA, intellectual property, Myriad, Patent Law, Prometheus, robin chadwick, Warren Woessner Leave a comment
Association For Molecular Pathology V Myriad Genetics – An Isolated Local Difficulty?
Paul Cole, Professor of Intellectual Property Law at Bournemouth University and European Patent Attorney at Lucas & Co, Warlingham, Surrey, UK discusses yesterdays Myriad ruling by the Supreme Court. How does yesterday’s Supreme Court decision match international opinion on the patentability … Continue reading